Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-18

Clinical Trial Update: Substrate Remodelling and Targeted Ablation in AF [NA]

View source ↗

Summary

The study, sponsored by Barts & The London NHS Trust, is testing substrate remodeling and targeted ablation strategies for atrial fibrillation. It focuses on id…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Barts & The London NHS Trust | Conditions: Atrial Fibrillation (AF), Atrial Fibrillation Mechanisms | NA | Status: RECRUITING